Buscar resultados de ensayos clínicos
Neuromyelitis Optica Spectrum Disorder - 28 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders Condición:
|
Active, not recruiting |
Nombre del estudio: A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD Condición:
|
Active, not recruiting |
Nombre del estudio: Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica Condición:
Fecha: 2011-05-31 Intervenciones: Biological: human umbilical cord mesenchymal stem cells Participants will be given hUC-MSCs transplantat |
Recruiting |
Nombre del estudio: A Longitudinal Study of Neuromyelitis Optica and Transverse Myelitis Condición:
|
Recruiting |
Nombre del estudio: Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct Condición:
Fecha: 2009-12-02 |
NOT_YET_RECRUITING |
Nombre del estudio: Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA� During Pregnancy Condición: Fecha: 2024-06-16 Intervenciones: Enrolled female participants with NMOSD who were exposed to UPLIZNA during pregnancy will be assessed.No study drug will be administered. |
NOT_YET_RECRUITING |
Nombre del estudio: Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders Condición: Fecha: 2024-06-16 Intervenciones: Inebilizumab: 300mg IV on Day1 and Day 15.The first dose of inelizumab is given during IVMP. |
RECRUITING |
Nombre del estudio: Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA� During Pregnancy Condición: Neuromyelitis Optica Spectrum Disorder Fecha: 2024-06-16 Intervenciones: Enrolled female participants with NMOSD who were exposed to UPLIZNA during pregnancy will be assessed.No study drug will be administered. |